购物车
- 全部删除
- 您的购物车当前为空
Tofacitinib Prodrug-1 是减轻托法替尼 (Tofacitinib) 全身性不良反应的口服有效前药。Tofacitinib Prodrug-1 能在小鼠模型有效减轻恶唑酮诱导的结肠炎,具有低毒性,是治疗溃疡性结肠炎的潜在候选药物。
Tofacitinib Prodrug-1 是减轻托法替尼 (Tofacitinib) 全身性不良反应的口服有效前药。Tofacitinib Prodrug-1 能在小鼠模型有效减轻恶唑酮诱导的结肠炎,具有低毒性,是治疗溃疡性结肠炎的潜在候选药物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 28,200 | 10-14周 | |
50 mg | ¥ 37,800 | 10-14周 | |
100 mg | ¥ 49,500 | 10-14周 |
产品描述 | Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis [1] . |
分子量 | 759.21 |
分子式 | C36H39ClN10O7 |
存储 | Shipping with blue ice. |
评论内容